<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: MicroRNAs (miRNAs) negatively regulate the gene expression and act as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressors or oncogenes in <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The association between single nucleotide polymorphism (SNP) in miR-196a2 rs11614913 and the susceptibility of <z:e sem="disease" ids="C0751075" disease_type="Neoplastic Process" abbrv="">digestive system cancers</z:e> was inconsistent in previous studies </plain></SENT>
<SENT sid="2" pm="."><plain>METHODOLOGY/PRINCIPAL FINDINGS: An updated meta-analysis based on 15 independent case-control studies consisting of 4999 cancer patients and 7606 controls was performed to address this association </plain></SENT>
<SENT sid="3" pm="."><plain>It was found that miR-196a2 polymorphism significantly elevated the risks of <z:e sem="disease" ids="C0751075" disease_type="Neoplastic Process" abbrv="">digestive system cancers</z:e> (CT vs. TT, OR = 1.25, 95% CI = 1.07-1.45; CC vs. TT, OR = 1.38, 95% CI = 1.13-1.67; CC/CT vs. TT, OR = 1.29, 95% CI = 1.10-1.50; CC vs. CT/TT, OR = 1.14, 95% CI = 1.01-1.30; C vs. T, OR = 1.15, 95% CI = 1.05-1.26) </plain></SENT>
<SENT sid="4" pm="."><plain>We also found that variant in miR-196a2 increased the susceptibility of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) (CT vs. TT, OR = 1.23, 95% CI = 1.04-1.44; CC vs. TT, OR = 1.32, 95% CI = 1.08-1.61; CC/CT vs. TT, OR = 1.25, 95% CI = 1.07-1.46; C vs. T, OR = 1.15, 95% CI = 1.05-1.28), while the association in recessive model (CC vs. CT/TT, OR = 1.16, 95% CI = 0.98-1.38) showed a marginal significance </plain></SENT>
<SENT sid="5" pm="."><plain>Additionally, significant association between miR-196a2 polymorphism and increased risk of hepatocellular <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (<z:mp ids='MP_0003331'>HCC</z:mp>) was detected </plain></SENT>
<SENT sid="6" pm="."><plain>By stratifying <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> on the basis of site of origin, source of controls, ethnicity and allele frequency in controls, elevated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risks were observed </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION/SIGNIFICANCE: Our findings suggest the significant association between miR-196a2 polymorphism and increased susceptibility of <z:e sem="disease" ids="C0751075" disease_type="Neoplastic Process" abbrv="">digestive system cancers</z:e>, especially of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, <z:mp ids='MP_0003331'>HCC</z:mp> and Asians </plain></SENT>
<SENT sid="8" pm="."><plain>Besides, C allele may contribute to increased <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">digestive cancer</z:e> risks </plain></SENT>
</text></document>